
News|Articles|April 25, 2008
Biovail receives approval for Aplenzin for depression
Aplenzin is a new drug from Biovail Corp. that has been approved to treat depression in adults
Advertisement
Aplenzin (bupropion hydrobromide), formerly known as BVF-033, is an antidepressant from Biovail Corp. that has just received approval from the Food & Drug Administration. The
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
COVID-19 Infection During First Trimester Increases Risk of Neonatal Risks
2
Maximizing Efficiency and Expansion of Vaccine Offerings in Pharmacy
3
Older Adults Lack Understanding of OTC Drugs Despite Common Use
4
Half of Patients Have Used Online Pharmacies But Under 10% Identified Safe Sites
5












































































































































